The Catalyst

Most Recent Posts

07.24.12 | By Mark Grayson

The Center for Safe Internet Pharmacy announced a new campaign to educate consumers about buying prescription drugs online.

07.23.12

Today we have a guest post from Marybeth McGuire, Director of Corporate Social Responsibility at Boehringer Ingelheim.

07.19.12 | By Kate Connors

Tomorrow, I leave PhRMA to try my hand at something new. It feels like a lifetime since I've been here - nearly six years. That's roughly one sixth of my 32 years, and longer than I've done anything in my life except for elementary school and aunthood.

07.18.12

Dr. John Lechleiter, Chairman of PhRMA's Board of Directors, has a piece worth reading over at Forbes today.

07.18.12 | By Jon Tripp

Jim would have been 64 this year. However, eight years ago today Orangeburg Department of Public Safety Police Captain James Myers was killed in a senseless act of violence at his farm in rural South Carolina.

I remember when I got the call - I was coming through the garage door having just returned from church that Sunday night.

07.17.12

I want to call attention to a recent Roll Call op-ed by Congressman Rick Larsen (D-Wash.) and Ed Gerwin, a senior fellow for trade at Third Way.

07.12.12 | By Preet Bilinski

Mental illness is not something you can see. There are millions of people who live with mental illnesses that go unseen. These diseases are biological brain disorders that have nothing to do with a person's character, and, like other illnesses, they require medical treatment for healing.

07.12.12

The other night, I watched a new police procedural on television. While the ultimate "bad guy" was a murderer who was part of a love triangle, at least one nefarious character under suspicion for the crime was a drug company scientist.

07.10.12 | By Greg Lopes

The Supreme Court has ruled, it's the middle of summer, and many people are on vacation and not focusing on healthcare, but I've been thinking about access and adherence to prescription medicines.

07.03.12 | By Greg Lopes

What if we had stopped innovating after discovering aspirin? Certainly we wouldn't have had the dramatic improvements in health outcomes that we've seen over the last hundred years. Over the years, medicines have played a key role in significantly reducing deaths, with major advances in treatments for heart disease, many cancers, and HIV/AIDS.

06.28.12 | By Greg Lopes

I'm excited to announce the launch of a new page on our Web site, PhRMA.org: "The Value of Medicines: Hope for Patients, Savings for the System." On this page, it is our intent to bring to your attention, in an easily digestible way, literature and research that examine the impact medicines have on patients' lives and to what extent improved health outcomes can affect health care costs.

It seems there are two fundamental questions around health care:

06.26.12 | By Greg Lopes

Over the years, I've learned that going to the pharmacy is not like a trip to the dentist - it's much less painful, and I'm always struck by how much pharmacists know and are willing to help. (Dentists are willing to help, but they often use a drill.)

06.26.12

Over the last several weeks, we've been fortunate to feature many blog posts on the Catalyst from prominent oncology researchers working for biopharmaceutical research companies. Many of these researchers have been active participants at various oncology conferences and events, such as the recent American Society of Clinical Oncology (ASCO) annual meeting, throughout the month of June. As these events wind down, we at PhRMA continue to reflect on progress that has been made in the war against cancer.

06.25.12

There has been a steady stream of media coverage out of last week's BIO meeting in Boston, Mass., highlighting the evolving biopharmaceutical research and development (R&D) model, particularly

Pages